Trials / Recruiting
RecruitingNCT06288282
Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (estimated)
- Sponsor
- Icahn School of Medicine at Mount Sinai · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Chronic lower back pain (CLBP) affects approximately 20% of the global population. The study objective is to determine if impulsivity, inhibitory control, drug choice, and/or cognitive distortions predict opioid misuse and disability in patients with chronic pain. This is a prospective consented cross-sectional study characterizing behavioral and cognitive phenotypes using both patient-reported survey measures and cognitive testing. Outcome measures include correlations between impulsivity measures, opioid drug choice responses and cognitive distortion scores, and risk for opioid misuse (Primary outcomes: COMM scores, SOAPPR scores). Secondary outcomes is BPI measurement. A Certificate of Confidentiality will provide additional protections for participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | No intervention will be used. |
Timeline
- Start date
- 2023-12-20
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2024-03-01
- Last updated
- 2025-06-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06288282. Inclusion in this directory is not an endorsement.